Barclays Maintains Overweight on NICE, Lowers Price Target to $286
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Tavy Rosner maintains an Overweight rating on NICE (NASDAQ:NICE) but lowers the price target from $320 to $286.

July 25, 2024 | 12:52 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Tavy Rosner maintains an Overweight rating on NICE but lowers the price target from $320 to $286.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some concerns or adjustments in expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100